These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
Pubmed for Handhelds
PUBMED FOR HANDHELDS
Journal Abstract Search
78 related items for PubMed ID: 9503555
21. Pharmacokinetics of tacrolimus and mycophenolate mofetil in renal transplant recipients on a corticosteroid-free regimen. Greanya ED, Poulin E, Partovi N, Shapiro RJ, Al-Khatib M, Ensom MH. Am J Health Syst Pharm; 2012 Jan 15; 69(2):134-42. PubMed ID: 22215359 [Abstract] [Full Text] [Related]
22. Effect of telmisartan, valsartan and candesartan on mycophenolate mofetil pharmacokinetics in Japanese renal transplant recipients. Miura M, Satoh S, Kagaya H, Saito M, Inoue T, Ohkubo T, Habuchi T, Suzuki T. J Clin Pharm Ther; 2009 Dec 15; 34(6):683-92. PubMed ID: 20175802 [Abstract] [Full Text] [Related]
23. Pharmacokinetics of mycophenolate mofetil in kidney transplant patients with renal insufficiency. González-Roncero FM, Gentil MA, Brunet M, Algarra G, Pereira P, Cabello V, Peralvo M. Transplant Proc; 2005 Nov 15; 37(9):3749-51. PubMed ID: 16386526 [Abstract] [Full Text] [Related]
24. Effect of cyclosporine withdrawal on mycophenolic acid pharmacokinetics in kidney transplant recipients with deteriorating renal function: preliminary report. Shipkova M, Armstrong VW, Kuypers D, Perner F, Fabrizi V, Holzer H, Wieland E, Oellerich M, MMF Creeping Creatinine Study Group. Ther Drug Monit; 2001 Dec 15; 23(6):717-21. PubMed ID: 11802109 [Abstract] [Full Text] [Related]
25. Pharmacokinetic and metabolic investigations of mycophenolic acid in pediatric patients after renal transplantation: implications for therapeutic drug monitoring. German Study Group on Mycophenolate Mofetil Therapy in Pediatric Renal Transplant Recipients. Oellerich M, Shipkova M, Schütz E, Wieland E, Weber L, Tönshoff B, Armstrong VW. Ther Drug Monit; 2000 Feb 15; 22(1):20-6. PubMed ID: 10688252 [Abstract] [Full Text] [Related]
26. Pharmacokinetics of mycophenolic acid and its glucuronidated metabolites in stable lung transplant recipients. Ting LS, Partovi N, Levy RD, Riggs KW, Ensom MH. Ann Pharmacother; 2006 Sep 15; 40(9):1509-16. PubMed ID: 16882870 [Abstract] [Full Text] [Related]
27. Decreased protein binding of mycophenolic acid associated with leukopenia in a pancreas transplant recipient with renal failure. Kaplan B, Gruber SA, Nallamathou R, Katz SM, Shaw LM. Transplantation; 1998 Apr 27; 65(8):1127-9. PubMed ID: 9583876 [Abstract] [Full Text] [Related]
28. Pharmacokinetics of Mycophenolate Mofetil Metabolites in Older Patients on the Seventh Day After Renal Transplantation. Sobiak J, Głyda M, Malec M, Chrzanowska M. Transplant Proc; 2021 Sep 27; 53(7):2212-2215. PubMed ID: 34412913 [Abstract] [Full Text] [Related]
29. The association of the UGT1A8, SLCO1B3 and ABCC2/ABCG2 genetic polymorphisms with the pharmacokinetics of mycophenolic acid and its phenolic glucuronide metabolite in Chinese individuals. Geng F, Jiao Z, Dao YJ, Qiu XY, Ding JJ, Shi XJ, Li ZD, Zhong MK. Clin Chim Acta; 2012 Apr 11; 413(7-8):683-90. PubMed ID: 22227166 [Abstract] [Full Text] [Related]
30. Population pharmacokinetics of mycophenolic acid and its glucuronide metabolite in lung transplant recipients with and without cystic fibrosis. Wang XX, Liu W, Zheng T, Park JM, Smith DE, Feng MR. Xenobiotica; 2017 Aug 11; 47(8):697-704. PubMed ID: 27686146 [Abstract] [Full Text] [Related]
34. Pharmacokinetics of mycophenolic acid and metabolites in diabetic kidney transplant recipients. Akhlaghi F, Patel CG, Zuniga XP, Halilovic J, Preis IS, Gohh RY. Ther Drug Monit; 2006 Feb 11; 28(1):95-101. PubMed ID: 16418701 [Abstract] [Full Text] [Related]
35. Effect of mycophenolate mofetil on hematological side effects incidence in renal transplant recipients. Sobiak J, Kamińska J, Głyda M, Duda G, Chrzanowska M. Clin Transplant; 2013 Feb 11; 27(4):E407-14. PubMed ID: 23758434 [Abstract] [Full Text] [Related]
36. Evaluation of MPA and MPAG removal by continuous venovenous hemodiafiltration and continuous venovenous hemofiltration. Cussonneau X, Bolon-Larger M, Prunet-Spano C, Bastien O, Boulieu R. Ther Drug Monit; 2008 Feb 11; 30(1):100-2. PubMed ID: 18223470 [Abstract] [Full Text] [Related]
37. Influence of MRP2 on MPA pharmacokinetics in renal transplant recipients-results of the Pharmacogenomic Substudy within the Symphony Study. Lloberas N, Torras J, Cruzado JM, Andreu F, Oppenheimer F, Sánchez-Plumed J, Gentil MÁ, Brunet M, Ekberg H, Grinyó JM, Spanish Pharmacogenetic Symphony Substudy Group. Nephrol Dial Transplant; 2011 Nov 11; 26(11):3784-93. PubMed ID: 21427078 [Abstract] [Full Text] [Related]
38. Significant Correlations between p-Cresol Sulfate and Mycophenolic Acid Plasma Concentrations in Adult Kidney Transplant Recipients. Rong Y, Colbourne P, Gourishankar S, Kiang TKL. Clin Drug Investig; 2022 Mar 11; 42(3):207-219. PubMed ID: 35182318 [Abstract] [Full Text] [Related]
39. Population pharmacokinetics of mycophenolic acid and its main glucuronide metabolite: a comparison between healthy Chinese and Caucasian subjects receiving mycophenolate mofetil. Ling J, Shi J, Jiang Q, Jiao Z. Eur J Clin Pharmacol; 2015 Jan 11; 71(1):95-106. PubMed ID: 25327506 [Abstract] [Full Text] [Related]
40. Cyclosporine alters correlation between free and total mycophenolic acid in kidney transplant recipients in the initial phase. Mino Y, Naito T, Otsuka A, Takayama T, Ozono S, Kagawa Y, Kawakami J. J Clin Pharm Ther; 2011 Apr 11; 36(2):217-24. PubMed ID: 21366651 [Abstract] [Full Text] [Related] Page: [Previous] [Next] [New Search]